image
Healthcare - Biotechnology - NASDAQ - US
$ 1.845
-5.45 %
$ 209 M
Market Cap
-0.01
P/E
CASH FLOW STATEMENT
-16.8 M OPERATING CASH FLOW
9.77%
-5 M INVESTING CASH FLOW
-34605.35%
22.5 M FINANCING CASH FLOW
41.32%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Aditxt, Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -35 M
Depreciation & Amortization 617 M
Capital Expenditures 0
Stock-Based Compensation 33.1 M
Change in Working Capital 7.09 M
Others -633 M
Free Cash Flow -16.8 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (35.0) (32.4) (27.6) (46.4) (9.1) (5.8) (5.7) (0.9)
Depreciation & Amortization 617.3 0.5 0.5 0.5 17.8 K 0 0 0
Deferred Income Tax 0 0 0 17.0 0 0 0 0
Stock Based Compensation 33.1 1.4 3.1 4.6 3.2 4.2 3.5 0.6
Other Operating Activities (639.2) 2.8 2.1 1.8 0.3 0.5 0.4 34.3 K
Change in Working Capital 7.1 9.1 (0.5) 0.1 (1.6) 1.1 1.4 0.2
Cash From Operations (16.8) (18.6) (22.4) (22.3) (7.2) (0.5) (0.4) 0
INVESTING CASH FLOW
Capital Expenditures 0 14.4 K (0.4) (1.0) (0.2) 0 0 0
Other Items (5.0) 0 0.1 (15.3) 0 0 0 0
Cash From Investing Activities (5.0) 14.4 K (0.2) (16.3) (0.2) 0 0 0
FINANCING CASH FLOW
Common Stock Repurchased (2.9) 1 K 20 K 0 0 0 0 0
Total Debt Repaid (1.4) 5.1 2.4 3.6 (0.3) 2 K 0.1 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 2.7 (0.3) 15.1 2.5 (0.3) (0.1) (0.5) 100 K
Cash From Financing Activities 22.5 15.9 17.5 36.0 17.9 0.4 0.5 100 K
CHANGE IN CASH
Net Change In Cash 0.7 (2.7) (5.1) (2.6) 10.5 (0.1) 90.7 K 100 K
FREE CASH FLOW
Free Cash Flow (16.8) (18.6) (22.8) (23.3) (7.4) (0.5) (0.4) 0